Literature DB >> 10702494

Sequential use of paraformaldehyde and methanol as optimal conditions for the direct quantification of ZEBRA and rta antigens by flow cytometry.

B M Imbert-Marcille1, M Coste-Burel, N Robillard, J Foucaud-Gamen, S Billaudel, E Drouet.   

Abstract

A technique was developed with flow cytometry to quantify the two immediate-early proteins ZEBRA and Rta, which are involved in the activation of Epstein-Barr virus replication. We evaluated four monoclonal antibodies on four cell lines (B95-8, RAJI, Namalwa, and P3HR1) with varying levels of expression of these replication-phase antigens. The Namalwa lymphoma cell line was used as a negative control. Four fixation-permeabilization procedures were compared. The preparation of cells with paraformaldehyde and methanol in sequence, and antigen detection with AZ125 and AR 5A9 monoclonal antibodies, were found to be the optimal conditions in these cell lines. Our procedure allowed ZEBRA antigen to be detected in 4.85% of peripheral blood mononuclear cells from a transplant recipient with a lymphoproliferative disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10702494      PMCID: PMC95850          DOI: 10.1128/CDLI.7.2.206-211.2000

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  28 in total

1.  High Epstein-Barr virus serum load and elevated titers of anti-ZEBRA antibodies in patients with EBV-harboring tumor cells of Hodgkin's disease.

Authors:  E Drouet; P Brousset; F Fares; J Icart; C Verniol; F Meggetto; D Schlaifer; H Desmorat-Coat; F Rigal-Huguet; A Niveleau; G Delsol
Journal:  J Med Virol       Date:  1999-04       Impact factor: 2.327

2.  The Epstein-Barr virus Rta protein activates lytic cycle genes and can disrupt latency in B lymphocytes.

Authors:  T Ragoczy; L Heston; G Miller
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

3.  Flow cytometric detection of EBV (EBER snRNA) using peptide nucleic acid probes.

Authors:  T Just; H Burgwald; M K Broe
Journal:  J Virol Methods       Date:  1998-08       Impact factor: 2.014

Review 4.  Epstein-Barr viral gene expression in B-lymphocytes.

Authors:  F Schwarzmann; M Jäger; M Hornef; N Prang; H Wolf
Journal:  Leuk Lymphoma       Date:  1998-06

5.  Immunofluorescence microscopy and flow cytometry characterization of chemical induction of latent Epstein-Barr virus.

Authors:  H B Jenson; G M Grant; Y Ench; P Heard; C A Thomas; S G Hilsenbeck; M P Moyer
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

6.  Development of a method for direct quantification of cytomegalovirus antigenemia by flow cytometry.

Authors:  B M Imbert-Marcille; N Robillard; A S Poirier; M Coste-Burel; D Cantarovich; N Milpied; S Billaudel
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

7.  Epstein-Barr virus-associated B cell lymphoproliferative disease after non-myeloablative allogeneic stem cell transplantation.

Authors:  N Milpied; M Coste-Burel; F Accard; A Moreau; P Moreau; R Garand; J L Harousseau
Journal:  Bone Marrow Transplant       Date:  1999-03       Impact factor: 5.483

8.  A gentle fixation and permeabilization method for combined cell surface and intracellular staining with improved precision in DNA quantification.

Authors:  I Schmid; C H Uittenbogaart; J V Giorgi
Journal:  Cytometry       Date:  1991

9.  Detection and quantification of Epstein-Barr virus EBER1 in EBV-infected cells by fluorescent in situ hybridization and flow cytometry.

Authors:  R P Stowe; M L Cubbage; C F Sams; D L Pierson; A D Barrett
Journal:  J Virol Methods       Date:  1998-11       Impact factor: 2.014

10.  Epstein-barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients.

Authors:  G J Babcock; L L Decker; R B Freeman; D A Thorley-Lawson
Journal:  J Exp Med       Date:  1999-08-16       Impact factor: 14.307

View more
  6 in total

1.  The lytic phase of epstein-barr virus requires a viral genome with 5-methylcytosine residues in CpG sites.

Authors:  Markus Kalla; Christine Göbel; Wolfgang Hammerschmidt
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

2.  Bendamustine reactivates latent Epstein-Barr virus.

Authors:  Samantha G Fernandez; J J L Miranda
Journal:  Leuk Lymphoma       Date:  2015-09-15

3.  Epstein-Barr virus latency type and spontaneous reactivation predict lytic induction levels.

Authors:  An T Phan; Samantha G Fernandez; Jessica J Somberg; Kristin M Keck; Jj L Miranda
Journal:  Biochem Biophys Res Commun       Date:  2016-04-16       Impact factor: 3.575

4.  Cross talk between EBV and telomerase: the role of TERT and NOTCH2 in the switch of latent/lytic cycle of the virus.

Authors:  S Giunco; A Celeghin; K Gianesin; R Dolcetti; S Indraccolo; A De Rossi
Journal:  Cell Death Dis       Date:  2015-05-28       Impact factor: 8.469

5.  Lytic EBV infection investigated by detection of Soluble Epstein-Barr virus ZEBRA in the serum of patients with PTLD.

Authors:  Mohammed Habib; Marlyse Buisson; Julien Lupo; Felix Agbalika; Gérard Socié; Raphaele Germi; Monique Baccard; Berthe-Marie Imbert-Marcille; Jacques Dantal; Patrice Morand; Emmanuel Drouet
Journal:  Sci Rep       Date:  2017-09-05       Impact factor: 4.379

6.  BZLF1 governs CpG-methylated chromatin of Epstein-Barr Virus reversing epigenetic repression.

Authors:  Anne Woellmer; Jose M Arteaga-Salas; Wolfgang Hammerschmidt
Journal:  PLoS Pathog       Date:  2012-09-06       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.